WHO faces uncertainty as U.S. withdrawal approaches
GENEVA, SWITZERLAND — The World Health Organization (WHO) wrapped up its eight-day executive board meeting in Geneva on Tuesday, facing the stark reality of the United States’ impending withdrawal.
The decision, announced by President Donald Trump on January 20, has initiated a one-year process for the U.S. to exit the UN health agency, leaving WHO grappling with significant financial and operational challenges.
WHO Director-General Dr. Tedros Adhanom Ghebreyesus voiced regret over the decision, saying, “We very much hope they will reconsider and we would welcome the opportunity to engage in constructive dialogue.”
The US delegation’s limited involvement during the meeting highlighted the growing divide between the organization and its largest donor.
WHO takes steps to address funding gaps
The U.S. withdrawal underscores WHO’s heavy reliance on voluntary contributions, which account for a large share of its $6.8 billion biennial budget. In response, the executive board proposed a 20% increase in membership fees as part of a broader strategy to secure more stable funding by 2030.
“This is a very strong signal of your support,” Dr. Ghebreyesus said, describing the move as “a major step towards putting WHO on a more predictable and sustainable financial footing.”
Barbados Health Minister Jerome Walcott, chair of the executive board, acknowledged the challenges but commended the board for reaching a consensus on 40 decisions and seven resolutions aimed at bolstering global public health efforts.
Global health programs at risk
The departure of the U.S. could have wide-ranging consequences for global health initiatives. Experts warn that reduced funding may hinder WHO’s ability to respond effectively to disease outbreaks and deliver critical programs such as vaccine distribution and emergency health interventions.
Despite these hurdles, WHO remains committed to addressing key health issues, including non-communicable diseases, environmental health, maternal care, and universal health coverage. The board also re-adopted a resolution on health conditions in Palestinian territories, with an estimated implementation cost of US$648 million.
